Coronary Physiology Training

In this interactive and hands-on training you will develop a thorough understanding on coronary physiology, coronary blood flow regulation in unobstructed and obstructed coronary arteries. You will learn what you need to know to implement iFR and FFR in your laboratory, about the guidelines for appropriate use, and how to use co-registration in daily practice to simplify treatment and improve patient care.

Course Information

Speaker

Dr Bon-Kwon Koo, Dr Paul JL Ong

Country

Singapore

Venue

Tan Tock Seng Hospital (TTSH)

Singapore

Status

Registration Closed

Registration Fee

SGD $1,000.00 per pax

*GST included

Seats Available

-

Summary

DEFINE PCI Unseen focal lesions cause residual ischemia


1 in 4 patients with angiographically successful PCI left the cath lab with residual ischemia.


Of the patients with residual ischemia, 81.6% were caused by an untreated angiographically inapparent physiologically focal stenosis (≤ 15 mm).


iFR Co-registration maps pressure drops right onto the angiogram, making it easy to:

  1. Identify the precise locations causing ischemia – each yellow dot signifies a 0.01 drop 
  2. Plan your treatment, before a stent is even placed, with a virtual stent
  3. Determine lesion lengths without need for a pullback device
  4. Predict physiologic gain with iFR estimate

Having the full physiologic picture from the start may make it less likely to miss important vessel segments that would otherwise result in residual ischemia. 


Learn more about iFR data and iFR Co-registration at www.philips.com/iFR.


About Speaker

Dr Bon-Kwon Koo

Dr. Bon-kwon Koo is an interventional cardiologist and a professor of Seoul National University College of Medicine. Dr. Koo trained at a Severance Hospital, Seoul, Korea and was a visiting scholar at Stanford University.

Dr. Koo is an interventional cardiologist and his main research interest is imaging and physiologic evaluation of coronary artery disease. Dr. Koo is the principal investigator of many domestic and international studies including Side branch FFR study, Bifurcation wedge study, International IMR registry study and 3V-FFR FRIENDS study. He has published more than 360 papers in major journals such as Lancet, JACC, Circulation and European Heart Journal.

He has been involved in many international meeting and is now serve as a course director of TCT-AP and a course co-director of ENCORE meeting. He has performed series of studies on bifurcation lesions and coronary physiology/imaging which provided important insights in this field.

His recent researches on non-invasive hemodynamic assessment using coronary CT angiography and computational fluid dynamics enables the assessment of FFR without invasive procedures and has started a new chapter in the diagnosis of coronary artery disease.

Dr Paul JL Ong

Dr. Paul Ong graduated from University of Cambridge. He became a member of the Royal College of Physicians in 1996 and was subsequently elected as Fellow of Royal College of Physicians (FRCP) in London and Fellow of the European Society of Cardiology (FESC) in 2008.

He completed his early medical training in some of the most prestigious London teaching hospitals including St Thomas’, University College and King’s College Hospitals. He obtained a British Heart Foundation Junior Fellowship to carry out research work with Professor Peter Collins at the National Heart and Lung Institute. The findings had been published in peer reviewed journals including the Lancet, Circulation and American Journal of Cardiology.

Dr. Ong obtained his cardiology specialist training in NW Thames gaining dual accreditation in Cardiology and General Medicine. He was awarded the Certificate of Completion of Specialist Training (CCST) in both specialties in 2004. He was a NHS Consultant Interventional Cardiologist and Cathlab Director at the Lister Hospital, Herts and Honorary Consultant Cardiologist at Royal Brompton and Harefield NHS Trust until 2008.

His main interests are in primary PCI and high-risk angioplasty with over 50 international publications in his field of interests. He is the organising chairman of the Asia Primary Angioplasty Congress. Paul also worked closely with CERC Asia and the Stent – Save a Life! global initiative. Dr. Ong has lectured and presented in numerous international meetings and has traveled to various parts of Asia to proctor and support new cardiac units.